Sandu Pharma Board to meet on May 5, 2026, for Q4/FY26 results & dividend

Sandu Pharmaceuticals Ltd announced that its Board of Directors will convene on May 5, 2026, at 3:00 p.m. at the Corporate Office in Mumbai. The primary agenda includes the consideration and approval of the Standalone Audited Financial Results for the quarter and financial year ended March 31, 2026. Additionally, the Board will discuss and potentially recommend a final dividend for the financial year ended March 31, 2026. In compliance with insider trading regulations, the trading window for the company's directors, officers, and designated employees has been closed from April 1, 2026, and will remain closed until 48 hours after the public announcement of the financial results.